Jamjoom Pharmaceuticals Factory Co. 4015

TADAWUL · Saudi Arabia · Health Technology

SAR 126.80+0.60 (+0.48%)

Market closed· Oct 1, 2026, 12:10 PM UTC· SAR · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Jamjoom Pharmaceuticals Factory Co. 4015

TADAWUL · Saudi Arabia · Health Technology

SAR 126.80+0.60 (+0.48%)

Market closed· Oct 1, 2026, 12:10 PM UTC· SAR · Data may be delayed

Company news

Yahoo FinanceJul 27, 2026

Idorsia advances global rollout of QUVIVIQ with Jamjoom Pharma partnership in Saudi Arabia and the Levant

Exclusive agreement with Jamjoom Pharma covers commercialization and distribution of QUVIVIQ™ (daridorexant) in Saudi Arabia and the Levant region Allschwil, Switzerland – July 27, 2026Idorsia Ltd (SIX: IDIA) has entered into an exclusive agreement with Jamjoom Pharmaceuticals Factory Co. (“Jamjoom Pharma”) for the distribution and commercialization of QUVIVIQ™ (daridorexant), Idorsia’s treatment for adults with insomnia, in Saudi Arabia and the Levant region. Benjamin Limal, President of Europe

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.

Prices may be delayed and are for informational purposes only - not investment advice.